[go: up one dir, main page]

Saransaari et al., 1999 - Google Patents

Taurine release is enhanced in cell-damaging conditions in cultured cerebral cortical astrocytes

Saransaari et al., 1999

View PDF
Document ID
5993256838221227999
Author
Saransaari P
Oja S
Publication year
Publication venue
Neurochemical research

External Links

Snippet

The release of preloaded [3H] taurine from cultured cerebral cortical astrocytes was studied under various cell-damaging conditions, including hypoxia, ischemia, aglycemia and oxidative stress, and in the presence of free radicals. Astrocytic taurine release was …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells

Similar Documents

Publication Publication Date Title
Matute et al. Glutamate‐mediated glial injury: Mechanisms and clinical importance
Nieoullon et al. The neuronal excitatory amino acid transporter EAAC1/EAAT3: does it represent a major actor at the brain excitatory synapse?
Schroeter et al. Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein
Wood et al. Capsaicin-induced ion fluxes in dorsal root ganglion cells in culture
D’Orlando et al. Calretinin and calbindin D-28k delay the onset of cell death after excitotoxic stimulation in transfected P19 cells
Chuang et al. N-methyl-D-aspartate exposure blocks glutamate toxicity in cultured cerebellar granule cells.
Bacskai et al. Activation of latent Ca2+ channels in renal epithelial cells by parathyroid hormone
Thomsen et al. A pharmacological characterization of the mGluR1α subtype of the metabotropic glutamate receptor expressed in a cloned baby hamster kidney cell line
Rossi et al. Modifications of Ca2+ signaling by inorganic mercury in PC 12 cells
Toro et al. Aging, ion channel expression, and vascular function
Trotti et al. Inhibition of the glutamate transporter EAAC1 expressed in Xenopus oocytes by phorbol esters
Buisson et al. DCG‐IV selectively attenuates rapidly triggered NMDA‐induced neurotoxicity in cortical neurons
Navarria et al. Alpha-synuclein modulates NR2B-containing NMDA receptors and decreases their levels after rotenone exposure
Saransaari et al. Characteristics of ischemia-induced taurine release in the developing mouse hippocampus
Brown et al. PrP and β‐amyloid fragments activate different neurotoxic mechanisms in cultured mouse cells
Tan et al. Downregulation of Nrf2/HO-1 pathway and activation of JNK/c-Jun pathway are involved in homocysteic acid-induced cytotoxicity in HT-22 cells
Benítez et al. Functional reduction of SK3-mediated currents precedes AMPA-receptor-mediated excitotoxicity in dopaminergic neurons
Saransaari et al. Taurine release is enhanced in cell-damaging conditions in cultured cerebral cortical astrocytes
Abdel-Hamid et al. The effects of artificial calcium buffers on calcium responses and glutamate-mediated excitotoxicity in cultured hippocampal neurons
Molchanova et al. Characteristics of basal taurine release in the rat striatum measured by microdialysis
Ma et al. Genistein inhibition of OGD-induced brain neuron death correlates with its modulation of apoptosis, voltage-gated potassium and sodium currents and glutamate signal pathway
Muller et al. Free radicals and glutamate uptake in the retina
Levi et al. Release studies related to the neurotransmitter role of glutamate in the cerebellum: an overview
Yıldızhan et al. Quipazine treatment exacerbates oxidative stress in glutamate-induced HT-22 neuronal cells
Segovia et al. Dopamine and GABA increases produced by activation of glutamate receptors in the nucleus accumbens are decreased during aging